Esomeprazole Magnesium

Spécifications

161973-10-0Numéro CAS

627-029-7Numéro CE

magnesium bis(5-methoxy-2-[(S)-(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]benzimidazol-1-ide)Nom IUPAC

C34H36MgN6O6S2Formule chimique

713.1 g/molMasse molaire

Esomeprazole magnesium; Nexium 24hr; 925R0D7W1O; CHEBI:50309; Esomeprazole Dr; RefChem:55131; Nexium 24HR ClearMinis; Esomeprazole Magnesium DR; Esomeprazole Magnesium D/r; DTXSID5044231; DTXCID901618215; Esomeprazole Magnesium Delayed-Release 20 mg mini; Esomeprazole Magnesium Delayed-Release Capsules, 20 mg; Esomeprazole Magnesium for delayed-release oral suspension; 161973-10-0; R6DXU4WAY9; Nexium; (-)-Omeprazole magnesium; (S)-Omeprazole magnesium; magnesium;5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide; Raciper; SCHEMBL144575; UNII-925R0D7W1O; SCHEMBL29386430; SCHEMBL29426631; KWORUUGOSLYAGD-YPPDDXJESA-N; GLXC-03022; Esomeprazole magnesium [USAN:INN]; D-961H; AKOS037515807; ESOMEPRAZOLE MAGNESIUM ANHYDROUS; CCG-270397; SB17371; OMEPRAZOLE S-FORM MANGESIUM SALT; E1443; OMEPRAZOLE S-FORM MANGESIUM SALT [MI]; H 199/18; H-199/18; Q27122029; 1H-BENZIMIDAZOLE, 5-METHOXY-2-((S)-((4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL)SULFINYL)-, MAGNESIUM SALT; 5-METHOXY-2-((S)-((4-METHOXY-3,5-DIMETHYL-2-PYRIDYL)METHYL)SULFINYL)BENZIMIDAZOLE, MAGNESIUM SALT (2:1); bis(5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide) magnesium; magnesium bis(5-methoxy-2-[(S)-(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]benzimidazol-1-ide); Magnesium, bis(5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazolato)-, (T-4-(S),(S))-; Magnesium, bis(5-methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl-kappaO)-1H-benzimidazolato-kappaN1)-, (T-4)-; MAGNESIUM, BIS(6-METHOXY-2-((S)-((4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL)SULFINYL-.KAPPA.O)-1H-BENZIMIDAZOLATO-.KAPPA.N3)-, (T-4)-; Esomeprazole Magnesium GranulesSynonymes